Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
3
KDLY Quote, Financials, Valuation and Earnings
Last price:
$1.12
Seasonality move
:
--
Day range:
$1.11 - $1.15
52-week range:
$0.65 - $4.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.19x
P/B ratio:
1.90x
Volume:
29.5K
Avg. volume:
718.9K
1-year change:
--
Market cap:
$6.6M
Revenue:
$3.8M
EPS (TTM):
-$0.53
Analysts' Opinion
-
Consensus RatingKindly MD has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Kindly MD has an estimated downside of -- from its current price of $1.11.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $1.11.
Fair Value
-
According to the consensus of 0 analysts, Kindly MD has -- downside to fair value with a price target of -- per share.
KDLY vs. S&P 500
-
Over the past 5 trading days, Kindly MD has underperformed the S&P 500 by -13.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kindly MD does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kindly MD has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kindly MD reported revenues of $647.9K.
Earnings Growth
-
Kindly MD has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Kindly MD reported earnings per share of -$0.17.
Enterprise value:
3.2M
EV / Invested capital:
0.86x
Price / LTM sales:
2.19x
EV / EBIT:
--
EV / Revenue:
1.10x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-1.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.7M
Return On Assets:
-100.72%
Net Income Margin (TTM):
-102.28%
Return On Equity:
-201.03%
Return On Invested Capital:
-137.75%
Operating Margin:
-162.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | $3.9M | $2.9M | $869.3K | $647.9K | |
| Gross Profit | -- | $3.7M | $2.7M | $849K | $640.1K | |
| Operating Income | -- | -$1.4M | -$2.6M | -$511.6K | -$1M | |
| EBITDA | -- | -$1.2M | -$2.3M | -$476.6K | -$955.2K | |
| Diluted EPS | -- | -$0.23 | -$0.53 | -$0.09 | -$0.17 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $3.9M | |
| Total Assets | -- | -- | -- | -- | $4.3M | |
| Current Liabilities | -- | -- | -- | -- | $725.9K | |
| Total Liabilities | -- | -- | -- | -- | $840.1K | |
| Total Equity | -- | -- | -- | -- | $3.5M | |
| Total Debt | -- | -- | -- | -- | $188.6K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$275.6K | -$2.4M | $34.2K | -$1M | |
| Cash From Investing | -- | -$119.4K | -$13.3K | -- | -$2.1K | |
| Cash From Financing | -- | $312.1K | $5.9M | $6.5K | -$49.6K | |
| Free Cash Flow | -- | -$395K | -$2.4M | $34.2K | -$1M | |
KDLY
Sector
Market Cap
$6.6M
$44.6M
Price % of 52-Week High
26.31%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
--
-29.09%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.20
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Sell
Level
1 - 1.52
Chaikin Money Flow
Sell
Level
-1M
20-day SMA
Sell
Level
$1.35
Relative Strength Index (RSI14)
Sell
Level
45.96
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-88.2022
50-day SMA
Sell
Level
$1.16
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-4
On Balance Volume
Neutral
Level
11.5M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-7.5809)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (13.6)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Stock Forecast FAQ
In the current month, KDLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KDLY average analyst price target in the past 3 months is --.
-
Where Will Kindly MD Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kindly MD share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Kindly MD?
Analysts are divided on their view about Kindly MD share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kindly MD is a Sell and believe this share price will rise from its current level to --.
-
What Is Kindly MD's Price Target?
The price target for Kindly MD over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is KDLY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kindly MD is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KDLY?
You can purchase shares of Kindly MD via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kindly MD shares.
-
What Is The Kindly MD Share Price Today?
Kindly MD was last trading at $1.12 per share. This represents the most recent stock quote for Kindly MD. Yesterday, Kindly MD closed at $1.11 per share.
-
How To Buy Kindly MD Stock Online?
In order to purchase Kindly MD stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
